Klaus Schwamborn
Bussiness And Management
Bling Consultants
United States of America
Biography
Klaus Schwamborn is currently leading as Vice President Vaccine Research at Valneva SE and serves as a director of BlinK Biomedical SAS. As a member of the Executive Committee at Valneva he is involved in the development and execution of Valneva’s strategy and operational oversight across all areas of the business. Before joining Valneva he held positions of increasing responsibility at Pepscan Therapeutics and Celgene. Klaus has more than 20 years international experience in drug discovery and research in infectious diseases and oncology including the areas of therapeutics antibodies and peptide based biologics. Klaus received his PhD from the University of Göttingen in 1998 and completed postdoctoral studies at the Institute Pasteur Paris.
Research Interest
Business
